Equities

Judges Scientific PLC

Judges Scientific PLC

Actions
  • Price (EUR)132.00
  • Today's Change4.00 / 3.13%
  • Shares traded5.00
  • 1 Year change+16.81%
  • Beta--
Data delayed at least 15 minutes, as of May 10 2024 07:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Judges Scientific plc is a United Kingdom-based company, which is focused on acquiring and developing companies within the scientific instrument sector. The Company's principal activities comprise the design, manufacture and sale of scientific instruments. Its subsidiaries are grouped into two segments: Materials Sciences and Vacuum. Its subsidiaries are primarily United Kingdom-based with products sold around the world to a diverse range of markets, including higher education institutions, the scientific communities, manufacturers, and regulatory authorities. The Company also specializes in the design and manufacture of instruments used for plasma surface treatment and provides plasma deposition services based on the instruments. Its subsidiaries include Armfield Limited, CoolLED Limited, Deben UK Limited, Dia-Stron Limited, EWB Solutions Limited, Korvus Technology Limited, Oxford Cryosystems Limited, PE.fiberoptics Limited, Quorum Technologies Limited and Scientifica Limited.

  • Revenue in GBP (TTM)136.10m
  • Net income in GBP9.50m
  • Incorporated2002
  • Employees714.00
  • Location
    Judges Scientific PLC52c Borough High StreetLONDON SE1 1XNUnited KingdomGBR
  • Phone+44 203 829 6970
  • Fax+44 134 232 3608
  • Websitehttps://www.judges.uk.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.